Company: TALK
Filing Date: 2025-03-12
Form Type: 10-K
Source: 0000950170-25-038107
Chunk: 100

Company: Talkspace, Inc.
Filing Date: 2025-03-12
Form: 10-K
Item: Item 1B
Chunk 100
---
683

    Net decrease in cash and cash equivalents

    (47,216
    )

    (14,637
    )

    (59,711
    )

    Cash and cash equivalents at the beginning of the year

    123,908

    138,545

    198,256

    Cash and cash equivalents at the end of the year
     
    $
    76,692

    $
    123,908

    $
    138,545

    Supplemental cash flow data:

    Cash paid during the year for interest
     
    $
    —

    $
    —

    $
    68

    Cash paid during the year for income taxes
     
    $
    96

    $
    219

    $
    122

    Non-cash investing activity:

    Lease liabilities arising from obtaining right-of-use assets
     
    $
    595

    $
    —

    $
    466

    Non-cash stock-based compensation capitalized in internal-use software costs
     
    $
    614

    $
    —

    $
    —

The accompanying notes are an integral part of the consolidated financial statements.

63

TALKSPACE, INC.

Notes to Consolidated Financial Statements 

NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONSTalkspace, Inc. (together with its consolidated subsidiaries, the “Company” or “Talkspace”) is a leading behavioral healthcare company enabled by a purpose-built technology platform. Talkspace provides individuals and licensed therapists, psychologists and psychiatrists with an online platform for one-on-one therapy delivered via messaging, audio and video. The Company offers convenient and affordable access to a fully credentialed network of highly qualified providers. Since its inception, the Company has connected millions of patients with licensed behavioral health providers across a wide and growing spectrum of care through virtual psychotherapy and psychiatry. The Company has three wholly-owned subsidiaries and holds variable interest in one professional association and various professional corporations, which have been established pursuant to the requirements of their respective domestic jurisdiction governing the corporate practice of medicine. These entities are considered Variable Interest Entities (“VIEs”). See Note 13, “Variable Interest Entities,” for further details.

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ESTIMATESBasis of PresentationThe consolidated financial statements and accompanying notes have been prepared in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”). In management’s opinion, the consolidated financial